E-LIB Suche - Ergebnisse für: Chie Kudo-Saito

1

Targeting SNCA in the treatment of malignant ascites in gas..:

Kudo-Saito, Chie ; Imazeki, Hiroshi ; Ozawa, Hiroki...
Translational Oncology. 48 (2024) - p. 102075 , 2024

2

Targeting Myeloid Determinants of Breast Cancer:

, In: Breast Cancer Genetics, Immunology, and Immunotherapy: An Interdisciplinary Approach; Interdisciplinary Cancer Research,

Kudo-Saito, Chie ; Ozaki, Yukinori - p. 255-285 , 2024

Link: https://doi.org/10.1007/..

3

546 The FSTL1-DIP2A axis as a promising target in the anti-..:

Naoki Takahashi ; Hirokazu Shoji ; Kengo Nagashima...
https://doaj.org/toc/2051-1426. , 2023

Link: https://doi.org/10.1136/..

4

Targeting myeloid villains in the treatment with immune che..:

Kudo-Saito, Chie ; Boku, Narikazu ; Hirano, Hidekazu.
Frontiers in Immunology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

5

Targeting AURKA in treatment of peritoneal tumor disseminat..:

Ozawa, Hiroki ; Imazeki, Hiroshi ; Ogiwara, Yamato...
Translational Oncology. 16 (2022) - p. 101307 , 2022

Link: https://doi.org/10.1016/..

6

Blocking FSTL1 boosts NK immunity in treatment of osteosarc..:

Ogiwara, Yamato ; Nakagawa, Makoto ; Nakatani, Fumihiko...
Cancer Letters. 537 (2022) - p. 215690 , 2022

Link: https://doi.org/10.1016/..

7

Targeting myeloid villains in the treatment with immune che..:

Chie Kudo-Saito ; Narikazu Boku ; Hidekazu Hirano.
https://www.frontiersin.org/articles/10.3389/fimmu.2022.1009701/full. , 2022

Link: https://doi.org/10.3389/..

8

Targeting AURKA in treatment of peritoneal tumor disseminat..:

Hiroki Ozawa ; Hiroshi Imazeki ; Yamato Ogiwara...
http://www.sciencedirect.com/science/article/pii/S1936523321002989. , 2022

Link: https://doi.org/10.1016/..

9

Targeting Oncoimmune Drivers of Cancer Metastasis:

Kudo-Saito, Chie ; Ozaki, Yukinori ; Imazeki, Hiroshi...
Cancers. 13 (2021) 3 - p. 554 , 2021

Link: https://doi.org/10.3390/..

10

CD11b+CTLA4+myeloid cells are a key driver of tumor evasion..:

Imazeki, Hiroshi ; Ogiwara, Yamato ; Kawamura, Mami..
Journal for ImmunoTherapy of Cancer. 9 (2021) 7 - p. e002841 , 2021

Link: https://doi.org/10.1136/..

11

Targeting Oncoimmune Drivers of Cancer Metastasis:

Chie Kudo-Saito ; Yukinori Ozaki ; Hiroshi Imazeki...
https://www.mdpi.com/2072-6694/13/3/554. , 2021

Link: https://doi.org/10.3390/..

12

Targeting Oncoimmune Drivers of Cancer Metastasis:

Chie Kudo-Saito ; Yukinori Ozaki ; Hiroshi Imazeki...
Cancer Therapy. , 2021

Link: https://doi.org/10.3390/..

13

CD11b+CTLA4+ myeloid cells are a key driver of tumor evasio..:

Hiroshi Imazeki ; Narikazu Boku ; Yamato Ogiwara..
https://jitc.bmj.com/content/9/7/e002841.full. , 2021

Link: https://doi.org/10.1136/..

14

Blocking the FSTL1-DIP2A Axis Improves Anti-tumor Immunity:

Kudo-Saito, Chie ; Ishida, Akiko ; Shouya, Yuji...
Cell Reports. 24 (2018) 7 - p. 1790-1801 , 2018

Link: https://doi.org/10.1016/..

15

Blocking the FSTL1-DIP2A Axis Improves Anti-tumor Immunity:

Chie Kudo-Saito ; Akiko Ishida ; Yuji Shouya...
http://www.sciencedirect.com/science/article/pii/S221112471831146X. , 2018

Link: https://doi.org/10.1016/..